Study Designs Used in PFAS Research
PFAS epidemiology employs several study designs, each with distinct strengths and limitations. Cohort studies follow exposed and unexposed populations prospectively, documenting who develops disease over time. The C8 Health Project — following over 69,000 people exposed to PFOA through contaminated water near DuPont’s facility — exemplifies this approach and has yielded the strongest evidence linking PFAS to specific health outcomes.
Cross-sectional studies analyze PFAS blood levels and health outcomes at a single point in time, providing associations but not proof of causality. NHANES has been particularly valuable for this purpose, providing nationally representative PFAS biomonitoring data linked to extensive health questionnaires and clinical measurements.
Biomonitoring: Measuring Exposure
PFAS blood serum levels are the standard exposure metric in epidemiological research. Blood PFAS concentrations reflect integrated exposure over years to decades due to long half-lives. Serum PFAS levels correlate with drinking water concentrations, dietary patterns, and occupational exposure, making them reliable biomarkers for exposure classification in epidemiological studies.
Spot urine samples capture short-chain PFAS that are eliminated renally more rapidly than long-chain compounds. For comprehensive PFAS exposure assessment, both serum and urine measurements may be used depending on the compounds of interest.
Challenges in Establishing Causality
The primary challenge in PFAS epidemiology is establishing causation rather than mere association. Confounding — where a third factor influences both PFAS exposure and health outcome — must be controlled through statistical methods. PFAS exposures rarely occur in isolation; people exposed to PFAS through contaminated water often have correlated exposures to other contaminants.
The long latency between early-life PFAS exposure and adult disease onset makes prospective studies logistically challenging. Biobanked samples from decades-old cohorts have been invaluable for retrospective PFAS analysis, and current investment in prospective birth cohorts will provide critical data in coming decades.